CLINICAL TRIAL CONSENTS:

ACTG Studies

 

CFAR Query Request Form

Cryopreservation IC V9 1/25/10 *EFFECTIVE 6/22/15

A5128 V4 IC V8 4/2/13 *EFFECTIVE 11/24/14

A5294 V2 IC V6 5/13/13 *EFFECTIVE 6/12/13

HPTN 069/A5305 V3 IC V8 9/29/14 *EFFECTIVE 10/15/14

A5308 V1 IC V4 5/2/14 *EFFECTIVE 8/21/14

A5314 V1 IC V6 6/17/15 *EFFECTIVE 6/30/15

A5315 V2 IC V6 2/5/15 *EFFECTIVE 2/19/15

A5318 V1 IC V2 5/16/13 *EFFECTIVE 6/19/13

A5320 V2 IC V4 2/20/15 *EFFECTIVE 3/30/15

A5321 V2 IC V6 5/7/15 *EFFECTIVE 5/21/15

A5322 V2 IC V4 2/19/15 *EFFECTIVE 6/29/15

A5326 V2 IC V5 10/30/14 *EFFECTIVE 2/9/15

A5327 V1 IC V3 6/26/14 *EFFECTIVE 7/15/14

A5329 V1 IC V2 8/13/14 *EFFECTIVE 7/28/15

A5332 V2 IC V4 6/2/15 *EFFECTIVE 6/10/15

A5333s V2 IC V2 5/22/15 *EFFECTIVE 6/10/15

A5340 V2 IC V3 5/20/15 *EFFECTIVE 7/1/15

Cocaine Use PET Scan IC V3 2/25/14 *EFFECTIVE 12/17/14

Promise V2 IC V6 3/28/13 *EFFECTIVE 5/2/13

Promise V2Pregnancy IC V4 5/9/13 *EFFECTIVE 11/24/14

Promise V2 stored specimen IC V3 11/5/12 *EFFECTIVE 12/20/12

Industry Studies

Bavarian Nordic POX-MVA-037 IC V4 12/5/14 *EFFECTIVE 3/2/15

EBOV-001 IC V2 4/22/15 *EFFECTIVE 5/20/15

Emend IV IC V2 3/17/14 *EFFECTIVE 2/9/15

Gilead US183-0145 IC V10 1/15/13 *EFFECTIVE 2/14/13

Gilead US216-0114 IC4 1/7/13 *EFFECTIVE 2/25/13

Gilead US216-0130 IC6 2/18/13 *EFFECTIVE 3/7/13

Gilead US236-0102 IC7 12/17/13 *EFFECTIVE 3/6/14

Gilead US236-0115 IC8 1/10/14 *EFFECTIVE 2/24/14

Gilead US248-0122 IC4 8/12/14 *EFFECTIVE 9/12/14

Gilead US248-0123 IC4 8/12/14 *EFFECTIVE 11/13/14

Gilead US264-0110 IC7 2/6/13 *EFFECTIVE 3/27/13

Gilead US292-0104 IC7 1/23/15 *EFFECTIVE 3/5/15

Gilead US292-0109 IC6 3/5/15 *EFFECTIVE 4/7/15

Gilead US292-0109 FIGHT DEXA IC2 5/15/13 *EFFECTIVE 7/17/13

Gilead US292-0111 IC5 1/24/15 *EFFECTIVE 3/5/15

Gilead US292-0112 IC7 2/16/15 *EFFECTIVE 4/14/15

Gilead US292-0112 PK/PD IC1 8/20/13 *EFFECTIVE 10/7/13

Gilead US292-0119 IC5 1/30/15 *EFFECTIVE 3/5/15

Gilead US292-0119 PK IC3 10/30/13 *EFFECTIVE 11/20/13

Gilead US336-1160 IC 3/17/15 *EFFECTIVE 4/7/15

Gilead US336-1216 IC 3/17/15 *EFFECTIVE 4/7/15

Gilead US336-1216 Dexa IC 3/17/15 *EFFECTIVE 4/7/15

Gilead US337-0115 IC V3 4/7/14 *EFFECTIVE 7/14/14

Gilead US337-0115 PK IC V3 4/7/14 *EFFECTIVE 7/14/14

Gilead US337-0115 PG IC V2 2/27/14 *EFFECTIVE 4/1/14

Gilead US337-0115 ReTX IC V3 4/7/14 *EFFECTIVE 7/14/14

GSK HIV011 IC V3 6/2/2012 *EFFECTIVE 2/4/13

GSK Aria - ING117172 IC V3 3/31/14 *EFFECTIVE 7/23/14

GSK Aria Rechallenge IC V1 10/28/13 *EFFECTIVE 7/23/14

GSK Aria Restart IC V1 10/28/13 *EFFECTIVE 7/23/14

HVTN 104 IC V2 4/3/15 *EFFECTIVE 4/13/15

IRC002 V7 IC V10 6/13/14 *EFFECTIVE 8/1/14

IRC003 V6 IC V3 1/26/15 *EFFECTIVE 1/30/15

Jean Boyer Venipuncture Study IC V5 5/24/12 *EFFECTIVE 1/14/15

Leukapheresis IC V4 3/28/14 *EFFECTIVE 4/28/14

Leukapheresis HLA+ IC 10/2/12 *EFFECTIVE 6/26/13

Merck MK-1436A-021 IC 6/16/15 *EFFECTIVE 6/22/15

Merck MK-1436A-021 FBR IC 6/16/15 *EFFECTIVE 6/22/15

Pfizer Poem A4001067 IC V5 3/21/12 *EFFECTIVE 2/28/13

PRO 140 IC V3 8/26/14 *EFFECTIVE 10/8/14

Sangamo LTFU V4 1/8/14 *EFFECTIVE 11/5/14

Sangamo SB-728mR V8 3/9/15 *EFFECTIVE 3/26/15

Statin HAND Study IC V2 8/22/13 *EFFECTIVE 2/16/15

Virxsys/Adapt LTFU 3/30/12 - *EFFECTIVE 9/4/14

 
 


About Penn Medicine   Contact Us   Site Map   Privacy Statement   Legal Disclaimer   Terms of Use

Penn Medicine, Philadelphia, PA 800-789-PENN © 2015, The Trustees of the University of Pennsylvania